In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection

32Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pseudomonas aeruginosa is an opportunistic and frequently drug-resistant pulmonary pathogen especially in cystic fibrosis sufferers. Recently, the frog skin-derived antimicrobial peptide (AMP) Esc(1-21) and its diastereomer Esc(1-21)-1c were found to possess potent in vitro antipseudomonal activity. Here, they were first shown to preserve the barrier integrity of airway epithelial cells better than the human AMP LL-37. Furthermore, Esc(1-21)-1c was more efficacious than Esc(1-21) and LL-37 in protecting host from pulmonary bacterial infection after a single intra-tracheal instillation at a very low dosage of 0.1 mg/kg. The protection was evidenced by 2-log reduction of lung bacterial burden and was accompanied by less leukocytes recruitment and attenuated inflammatory response. In addition, the diastereomer was more efficient in reducing the systemic dissemination of bacterial cells. Importantly, in contrast to what reported for other AMPs, the peptide was administered at 2 hours after bacterial challenge to better reflect the real life infectious conditions. To the best of our knowledge, this is also the first study investigating the effect of AMPs on airway-epithelia associated genes upon administration to infected lungs. Overall, our data highly support advanced preclinical studies for the development of Esc(1-21)-1c as an efficacious therapeutic alternative against pulmonary P. aeruginosa infections.

References Powered by Scopus

Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America

4112Citations
N/AReaders
Get full text

Peptide therapeutics: Current status and future directions

2319Citations
N/AReaders
Get full text

Peptide antimicrobial agents

2124Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review

1041Citations
N/AReaders
Get full text

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields

283Citations
N/AReaders
Get full text

Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates

110Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, C., Mangoni, M. L., & Di, Y. P. (2017). In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection. Scientific Reports, 7(1). https://doi.org/10.1038/s41598-017-08361-8

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 21

68%

Researcher 8

26%

Professor / Associate Prof. 2

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 11

46%

Agricultural and Biological Sciences 6

25%

Pharmacology, Toxicology and Pharmaceut... 4

17%

Chemistry 3

13%

Save time finding and organizing research with Mendeley

Sign up for free